Filter Results:
(70)
Show Results For
- All HBS Web
(70)
- News (28)
- Research (34)
- Multimedia (1)
- Faculty Publications (24)
Show Results For
- All HBS Web
(70)
- News (28)
- Research (34)
- Multimedia (1)
- Faculty Publications (24)
- 01 Dec 2005
- News
Pedal Mettle
player who was diagnosed with Hodgkin’s disease in 1995, Berté saw the cancer return six months after she completed her initial treatment. She then enrolled in a clinical trial including chemotherapy,... View Details
- 02 Aug 2011
- News
A Fearless Force for Change
founded with her husband Dave Linn (MBA '00) to fund research and clinical trials at Memorial Sloan-Kettering Cancer Center. Linn died July 20 at the age of 40. Diagnosed with a soft-tissue sarcoma (a... View Details
- Web
Kraft Precision Medicine Accelerator - Health Care
Faculty & Research Kraft Precision Medicine Accelerator About the Kraft Precision Medicine Accelerator From 2015–2020, the Harvard Business School Kraft Precision Medicine Accelerator (KPMA) worked to create business solutions which would help solve View Details
Larissa Bifano
computer databases, solid state devices and wireless positioning systems; medical technologies, including cancer treatment therapies, health and fitness monitoring and implantable devices; and various other technologies including... View Details
Keywords: Legal
- 10 Nov 2020
- News
Learning to Fight
Eventually, he found a treatment trial at the Mayo Clinic that was testing a new combination of chemotherapy and high-dose radiation. Slowly, Susan’s tumor began to shrink, until there was nothing left but scar tissue. Although she would... View Details
Keywords: April White
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
data and machine learning to improve health care. Kelley, who recently received a Blavatnik Fellowship in Life Science Entrepreneurship at HBS, aims to bring fast and accurate diagnoses to cancer patients around the world. “The majority... View Details
Keywords: Susan Young
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
the anatomical—basis of the disease." Genzyme, which currently has drugs in clinical trials for melanoma and breast cancer, hopes to have its first products on the market as early as 2004. "I think we're going to see more people... View Details
- 01 Jun 2000
- News
The Business of Biotech
currently has drugs in clinical trials for mela-noma and breast cancer, hopes to have its first products on the market as early as 2004. "I think we're going to see more people in the next decade who are living with View Details
Keywords: Julia Hanna
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new View Details
Keywords: Sean Silverthorne
- Web
THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement
Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS Insurance/payor Medical... View Details
- 19 Jun 2019
- News
Connecting Patients and Providers
Greg Jarzabek (PLD 21, 2016) was living in London and working in finance when his mother was diagnosed with terminal pancreatic cancer in her native Poland. Jarzabek wanted to reach out to doctors around the world to review and discuss... View Details
Keywords: April White
- 09 Feb 2010
- First Look
First Look: Feb. 9
human patients. Doyle believes NovoCure has the potential to become an important company with a major new cancer therapy platform but must complete pivotal (Phase III) clinical trials and receive FDA... View Details
Keywords: Martha Lagace
- Web
Teaching Cases - Institute For Strategy And Competitiveness
Health Delivery Project The Institute for Cancer Care Innovation MOC Network ICIC U.S. Cluster Mapping Project U.S. Competitiveness Project FSG Shared Value Initiative Social Progress Imperative AllWorld Network VBHCD Initiative VBHCD... View Details
- 01 Mar 2016
- News
Off Script
are following their own business models—whether they are for-profit or not-for-profit. The additional spend on health care is due to increased utilization of health-care services as the population gets older. Costlier innovations and longer patient lives in areas such... View Details
- 01 Dec 2013
- News
Your Own Medicine
WILLIAMS CHARLEY SECKLER in the midst of the first-ever trial for a DMD treatment at Johns Hopkins University. Photo courtesy the Seckler Family by Dan Morrell There's this picture of Charley Seckler from last summer that his mom has sent... View Details
- 01 Dec 2009
- News
Seven Honored with Alumni Achievement Award
Merck, Gillette, and Searle, Kathy Giusti was diagnosed in 1996 with multiple myeloma, a rare and incurable blood cancer. She then founded the Multiple Myeloma Research Foundation and the Multiple Myeloma Research Consortium, organizations that have revolutionized... View Details
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
aspects of the drug trial and approval process, including allowing time for potential issues to materialize. When you see an FDA emergency approval for a COVID-19 vaccine, don't interpret this as a normal “FDA approval.” I understand that... View Details
- 01 Dec 2013
- News
Curing Health Care
fundraising, IP, patent law, and the ins and outs of FDA and HIPAA regulations. Tecco and Gross refined their vision for Rock Health in a field study with HBS senior lecturer Bob Higgins. But first, Tecco had the experience of founding Yoga Bear, a nonprofit that... View Details
- 07 Oct 2014
- First Look
First Look: October 7
the Multiple Myeloma Research Foundation What do you do when your rising professional career is cut short by an unexpected cancer diagnosis? Kathy Giusti shifted careers, built a new organization that transformed how View Details
Keywords: Sean Silverthorne
- 03 Mar 2017
- News
Big Blue’s Big Bet
of the UNC Lineberger Comprehensive Cancer Center. Besides reading all the medical journals, Watson could inform doctors of when certain drug trials began and when others ended; it could also sequence a... View Details
Keywords: Paul Kix; illustrations by Dan Page